vor 5 Jahren

Impfstoff-Aktien: Suche nach dem Boden - Keine Begeisterung über Curevacs Einstieg in Grippevakzine

Erneut verzeichnen die meisten Titel Verluste. Auch Glaxos und Curevacs Einstieg in Grippevakzin-Studien kann nicht begeistern. Von Julia Groß, Euro am Sonntag

Quelle: Börse Online RSS Feed

Blockchain.com Scammed me out of $27,000 USDvor 13 Stunden
Bag holders getting wrecked hard af , will be the longest bear season to date you hear here 1stvor 14 Stunden
⚡ Lightning Thursday! October 22, 2026: Explore the Lightning Network!⚡vor 15 Stunden
Daily Discussion, October 22, 2026vor 16 Stunden
Apparently a Class Action Lawsuit has been Filed against CoinKite, the Makers of ColdCard, for their Entropy-less Bug that cost users $116 Millionvor 20 Stunden
BTC资金回来了，趋势确认了吗？vor 21 Stunden
[ Removed by Reddit ]vor 21 Stunden
How do you keep a small BTC perps loss from turning into a bigger one?vor 21 Stunden
[ Removed by Reddit ]vor 23 Stunden
Why do people think Bitcoin can replace currency?vor 23 Stunden